How psychological factors cause or worsen ED, the role of performance anxiety, and why apomorphine targets the neurological side of arousal.
Up to 40% of ED cases are primarily psychological — meaning the disruption occurs in the brain's arousal circuitry before it ever reaches blood vessels. The most common mechanism is performance anxiety: the fear of not being able to perform creates a self-fulfilling cycle.
When anxiety is present, the sympathetic nervous system activates — releasing adrenaline, which constricts blood vessels. This is the opposite of what an erection requires (vasodilation). One failed attempt creates anticipation of future failure, which creates the physiological conditions for failure.
Sexual arousal begins with dopamine. When a man encounters a sexually stimulating stimulus, dopamine is released in the mesolimbic and hypothalamic pathways — the brain's arousal and reward circuits. This dopamine signal is what initiates the downstream cascade that ultimately results in erection. When anxiety, depression, or stress suppress dopamine signaling, the arousal initiation fails before any vascular mechanism can occur.
This is precisely why apomorphine — a dopamine D1/D2 receptor agonist — is included in 3-in-1 and 4-in-1 combination formulas. For men whose ED has a strong psychological component, adding dopaminergic arousal support to PDE5-based blood flow enhancement can produce results that neither ingredient achieves alone.
Formulas containing apomorphine directly target the neurological arousal pathway. These include MEDVi Quad (4-in-1), BraveRx Surge Max (3-in-1), DirectMax (3-in-1), and Rugiet Ready (3-in-1). Hims 3-in-1 uses oxytocin instead — targeting the relational and anxiety-reduction dimension rather than dopamine signaling directly.